World

Second malaria vaccine highly protective, trial results show

LONDON, (Reuters) – A malaria vaccine developed by the University of Oxford and the Serum Institute of India prevented around three-quarters of symptomatic malaria cases in young children the first year after they got the shots, results from a large trial showed on Thursday.

Today's Paper

The ePaper edition, on the Web & in stores for Android, iPhone & iPad.

Included free with your web subscription. Learn more.